|
US7232899B2
(en)
|
1996-09-25 |
2007-06-19 |
The Scripps Research Institute |
Adenovirus vectors, packaging cell lines, compositions, and methods for preparation and use
|
|
AU4070499A
(en)
|
1998-04-30 |
1999-11-16 |
Cornell Research Foundation Inc. |
Adenoviral vectors with tandem fiber proteins
|
|
US6455314B1
(en)
|
1998-09-11 |
2002-09-24 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
|
EP1020529B1
(en)
*
|
1998-11-20 |
2005-06-01 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
|
IL133032A
(en)
*
|
1998-11-20 |
2007-06-03 |
Introgene Bv |
Adenoviral gene delivery vectors provided with a tissue tropism for smooth muscle cells and /or endothelial cells
|
|
JP2000279178A
(ja)
*
|
1999-02-24 |
2000-10-10 |
Japan Found Cancer Res |
ウイルスベクター
|
|
DE19932688B4
(de)
*
|
1999-07-13 |
2009-10-08 |
Scil Proteins Gmbh |
Design von Beta-Faltblatt-Proteinen des gamma-II-kristallins antikörperähnlichen
|
|
AU783879B2
(en)
*
|
1999-11-25 |
2005-12-15 |
Transgene S.A. |
Modified adenovirus fibre and uses
|
|
CA2410665C
(en)
*
|
2000-05-31 |
2017-11-07 |
University Of Saskatchewan |
Modified bovine adenovirus having altered tropism
|
|
IL153143A0
(en)
*
|
2000-06-02 |
2003-06-24 |
Novartis Ag |
Adenovirus particles with mutagenized fiber proteins
|
|
CA2491805A1
(en)
*
|
2002-07-10 |
2004-01-22 |
Transgene S.A. |
Modified adenoviral fiber with ablated binding to cellular receptors
|
|
US20060281090A1
(en)
*
|
2003-05-01 |
2006-12-14 |
University Of Washington Uw Tech Transfer- Invention Licensing |
Capsid-modified adenovirus vectors and methods of using the same
|
|
AU2004238979B2
(en)
*
|
2003-05-14 |
2008-12-18 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Broadening adenovirus tropism
|
|
DE10324447A1
(de)
|
2003-05-28 |
2004-12-30 |
Scil Proteins Gmbh |
Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin
|
|
GB0313132D0
(en)
|
2003-06-06 |
2003-07-09 |
Ich Productions Ltd |
Peptide ligands
|
|
WO2005030927A2
(en)
*
|
2003-09-23 |
2005-04-07 |
Uab Research Foundation |
Methods and compositions for in vivo inflammation monitoring
|
|
SI2163260T1
(sl)
*
|
2004-01-23 |
2017-07-31 |
Msd Italia S.R.L. |
Nosilci šimpanzjih adenovirusnih cepiv
|
|
DE102004049479A1
(de)
|
2004-10-11 |
2006-04-13 |
Scil Proteins Gmbh |
Proteinkonjugate zur Verwendung in Therapie, Diagnose und Chromatographie
|
|
US20070010016A1
(en)
*
|
2005-03-11 |
2007-01-11 |
Mccelland Alan |
Gene transfer with adenoviruses having modified fiber proteins
|
|
JP5475279B2
(ja)
*
|
2005-06-17 |
2014-04-16 |
イステイチユート・デイ・リチエルケ・デイ・ビオロジア・モレコラーレ・ピ・アンジエレツテイ・エツセ・エルレ・エルレ |
Ｃ型肝炎ウイルス核酸ワクチン
|
|
WO2007094653A1
(en)
*
|
2006-02-13 |
2007-08-23 |
Vereniging Voor Christelijk Hoger Onderwijs, Wetenschappelijk Onderzoek En Patientenzorg |
Adenovirus particles having a chimeric adenovirus spike protein, use thereof and methods for producing such particles.
|
|
EP1925664A1
(en)
*
|
2006-11-15 |
2008-05-28 |
Scil proteins GmbH |
Artificial binding proteins based on a modified alpha helical region of ubiquitin
|
|
US10131921B2
(en)
*
|
2008-03-06 |
2018-11-20 |
Mayo Foundation For Medical Education And Research |
Single cycle replicating adenovirus vectors
|
|
KR101436222B1
(ko)
|
2009-12-14 |
2014-09-01 |
쉴 프로테인즈 게엠베하 |
리간드 결합능력을 가진 헤테로-다량체 변형 유비퀴틴 단백질을 확인하는 방법
|
|
EP2721152B1
(en)
|
2011-06-15 |
2019-03-27 |
Navigo Proteins GmbH |
Dimeric binding proteins based on modified ubiquitins
|
|
SG11201507393TA
(en)
|
2013-03-14 |
2015-10-29 |
Salk Inst For Biological Studi |
Oncolytic adenovirus compositions
|
|
PL3198009T3
(pl)
|
2014-09-24 |
2022-01-24 |
Salk Institute For Biological Studies |
Onkolityczne wirusy nowotworowe i sposoby zastosowania
|
|
EP3253785B1
(en)
|
2015-02-06 |
2019-04-10 |
Navigo Proteins Gmbh |
Novel egfr binding proteins
|
|
CN107922483B
(zh)
|
2015-07-16 |
2021-07-30 |
纳维格蛋白质有限公司 |
新型免疫球蛋白结合蛋白及其在亲和纯化中的用途
|
|
WO2017013136A1
(en)
|
2015-07-20 |
2017-01-26 |
Scil Proteins Gmbh |
Novel binding proteins based on di-ubiquitin muteins and methods for generation
|
|
JP7054527B2
(ja)
|
2016-02-23 |
2022-04-14 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
アデノウイルスの複製動態を測定するための高スループットアッセイ
|
|
JP7015551B2
(ja)
|
2016-02-23 |
2022-02-15 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
ウイルス動態への影響を最小限にするための治療用アデノウイルスにおける外因性遺伝子発現
|
|
AU2017260274A1
(en)
|
2016-05-04 |
2018-11-01 |
Navigo Proteins Gmbh |
Targeted compounds for the site-specific coupling of chemical moieties comprising a peptide linker
|
|
CA3030208A1
(en)
|
2016-08-11 |
2018-02-15 |
Navigo Proteins Gmbh |
Novel alkaline stable immunoglobulin binding proteins
|
|
WO2018035387A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018035388A1
(en)
|
2016-08-17 |
2018-02-22 |
The Broad Institute, Inc. |
Novel crispr enzymes and systems
|
|
WO2018111767A1
(en)
|
2016-12-12 |
2018-06-21 |
Salk Institute For Biological Studies |
Tumor-targeting synthetic adenoviruses and uses thereof
|
|
US12350368B2
(en)
|
2017-04-14 |
2025-07-08 |
The Broad Institute, Inc. |
Delivery of large payloads
|
|
WO2019135816A2
(en)
|
2017-10-23 |
2019-07-11 |
The Broad Institute, Inc. |
Novel nucleic acid modifiers
|
|
US11414466B2
(en)
|
2017-11-07 |
2022-08-16 |
Navigo Proteins Gmbh |
Fusion proteins with specificity for ED-B and long serum half-life for diagnosis or treatment of cancer
|
|
EP3710039A4
(en)
|
2017-11-13 |
2021-08-04 |
The Broad Institute, Inc. |
METHODS AND COMPOSITIONS FOR TREATMENT OF CANCER BY TARGETING THE CLEC2D-KLRB1 PATH
|
|
JP7430395B2
(ja)
|
2018-04-09 |
2024-02-13 |
ソーク インスティテュート フォー バイオロジカル スタディーズ |
複製特質が増強された腫瘍溶解性アデノウイルス組成物
|
|
AU2019406778A1
(en)
|
2018-12-17 |
2021-07-22 |
Massachusetts Institute Of Technology |
Crispr-associated transposase systems and methods of use thereof
|
|
CA3123986A1
(en)
|
2018-12-18 |
2020-06-25 |
Navigo Proteins Gmbh |
Novel folr1 specific binding proteins for cancer diagnosis and treatment
|
|
WO2020236972A2
(en)
|
2019-05-20 |
2020-11-26 |
The Broad Institute, Inc. |
Non-class i multi-component nucleic acid targeting systems
|
|
US12297426B2
(en)
|
2019-10-01 |
2025-05-13 |
The Broad Institute, Inc. |
DNA damage response signature guided rational design of CRISPR-based systems and therapies
|
|
US11149286B1
(en)
|
2020-08-17 |
2021-10-19 |
Mayo Foundation For Medical Education And Research |
Adenovirus vectors and methods for using adenovirus vectors
|
|
CA3255225A1
(en)
|
2022-04-04 |
2023-10-12 |
The Regents Of The University Of California |
COMPOSITIONS AND METHODS OF GENETIC COMPLEMENTATION
|
|
WO2025072383A1
(en)
|
2023-09-25 |
2025-04-03 |
The Broad Institute, Inc. |
Viral open reading frames, uses thereof, and methods of detecting the same
|
|
WO2025097055A2
(en)
|
2023-11-02 |
2025-05-08 |
The Broad Institute, Inc. |
Compositions and methods of use of t cells in immunotherapy
|
|
WO2025129158A1
(en)
|
2023-12-15 |
2025-06-19 |
The Broad Institute, Inc. |
Engineered arc delivery vesicles and uses thereof
|
|
WO2025250808A1
(en)
|
2024-05-29 |
2025-12-04 |
The Brigham And Women’S Hospital, Inc. |
Anti-crispr delivery compositions and methods
|